Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 17, 2009
Cystamine prevents MPTP-induced toxicity in young adult mice via the up-regulation of the brain-derived neurotrophic factorC Gibrat, M Bousquet, M Saint-Pierre, et al.
Molecular Pharmacology|November 1, 1996
Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanineM Morissette, M Goulet, F Calon, et al.
Neurochemistry International|July 14, 1999
Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)/benzodiazepine receptor complex and GABA contentF Calon, M Morissette, M Goulet, et al.
Annals of Neurology|April 13, 2000
Molecular basis of levodopa-induced dyskinesiasF Calon, R Grondin, M Morissette, et al.
Experimental Neurology|April 29, 2000
125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatmentsF Calon, M Morissette, M Goulet, et al.
Neuroscience|July 1, 1997
Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysisM Goulet, M Morissette, F Calon, et al.
Brain Research. Molecular Brain Research|December 5, 1997
Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapyM Morissette, M Goulet, J J Soghomonian, et al.
Brain Research|May 22, 1995
Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complexF Calon, M Goulet, P J Blanchet, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeysP J Blanchet, F Calon, J C Martel, et al.
Synapse (New York, N.Y.)|April 17, 2001
Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporterF Calon, N Lavertu, A M Lemieux, et al.
Pageof 3